Ernexa Therapeutics Inc. Total Shareholder Rtn Amt
Ernexa Therapeutics Inc. (ERNA) reported Total Shareholder Rtn Amt of $0.02 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-05-11.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-05-11
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $0.02 DEF 14A · filed 2026-05-11 |
| 2024-12-31 | $0.07 DEF 14A · filed 2026-05-11 |
| 2023-12-31 | $0.42 DEF 14A · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |